Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)

Exclusion Criteria

• •Pregnant or lactating women.
• •History of anaphylaxis and/or other severe local reaction(s) to skin testing.
• •History of positive test for HIV, Hepatitis B or Hepatitis C infection.
• •Documented evidence of acute or significant chronic sinusitis or chronic purulent postnasal drip.
• •Subjects with an active pulmonary disorder or infection.
• •Subjects with posterior subcapsular cataracts or glaucoma
• •Plans to travel outside the known pollen area for the investigational site for 24 hours or longer during the last 7 days of the run-in period.